Studying familial systemic scleroderma
Part of Immune system & allergy, Skin clinical trials.
This study looks at families where two first-degree relatives have systemic scleroderma, a rare autoimmune disease that affects the skin and organs. It aims to understand genetic and environmental factors by examining patients and their family members.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- You have been diagnosed with systemic scleroderma by a doctor, including limited, diffuse, or sine scleroderma, or overlap syndromes with myositis.
- You have at least one first-degree relative (parent, sibling, or child) who also has systemic scleroderma and meets the same diagnosis rules.
- You do not have any condition or objection that would prevent you from agreeing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special camera (SFDI) to take painless images of your skin to see how scleroderma affects it. You may also be asked for a small skin sample (biopsy) to help understand the condition better.
This study is looking at how systemic sclerosis (a disease that can cause skin thickening and organ problems) affects muscles. It may help find better ways to care for patients.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study is looking at people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect internal organs) to learn more about the disease. You may join if you have been diagnosed with this condition and meet a few other requirements.
This research study uses special lab-grown stem cells to understand how systemic sclerosis (a disease that hardens skin and organs) develops and progresses. By studying cells from patients with different types of systemic sclerosis and healthy relatives, researchers hope to find new ways to treat or prevent the disease.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
Hear when a new Systemic Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.